What Are Movement Disorders?

  • Shiyi Liang Medical Biosciences, Imperial College London

A movement disorder is a neurological condition that affects your movement, either by increasing or reducing it. The affected movement can be voluntary or involuntary. There are many factors contributing to movement disorders, genetic factors, ageing, and brain trauma are typically mentioned. 

With millions of patients suffering from some kind of movement disorder globally, a better understanding of movement disorders may help overcome the challenges faced by patients and create a better living environment for them. 

This article discusses the various types of movement disorders, the mechanisms underpinning their development, and the symptoms associated with them. We will also explore promising pharmacological interventions and therapeutic techniques that are enhancing patients' lives.

Introduction

Movement disorders are a group of neurological disorders that affect your movement. These disorders can increase or decrease both conscious (voluntary) and subconscious (involuntary) movements. If you have a movement disorder, you may find it difficult to plan, control or execute various movements. This often manifests as symptoms like uncontrolled muscle contraction, uncoordinated balance, and even cognitive problems.

The Parkinson and Movement Disorder Alliance have suggested more than 40 million people are affected by movement disorders.1 It is important to raise awareness of movement disorders and promote early diagnosis. As there is no complete cure for movement disorders yet, research into the development of effective treatments and preventative measures could significantly improve patient’s quality of life. 

Types of movement disorders

Movement disorders can be classified into three main categories: neurodegenerative, hyperkinetic (increased movement) and hypokinetic (reduced movement).  

Neurodegenerative movement disorders

The most common neurodegenerative movement disorders include Parkinson’s Disease (PD), Huntington’s Disease (HD) and Amyotrophic Lateral Sclerosis (ALS). In these neurodegenerative disorders, neurons (the main cells that make up our central nervous system) break down, degenerate, or die, affecting normal movement and activity. These neurodegenerative movement disorders mostly appear and progress as patients age. 

Parkinson’s disease

Parkinson’s disease is caused by the loss and lack of neurons in the basal ganglia (the region of the brain responsible for controlling movement) - specifically, the neurons responsible for producing dopamine.2 Individuals with PD may suffer from tremors in their limbs or jaw and experience difficulty in swallowing and chewing.

Huntington’s disease (or Huntington’s chorea)

Huntington’s disease is caused by a mutation in the IT1 gene, which affects the production of a protein called Huntingtin. This mutated product can negatively affect essential cellular functions and lead to neuron death.3 Huntington’s often appears early in adult life, with symptoms typically appearing around 37 years of age. However, this can vary.2 Typical symptoms include involuntary twisting and jerking and unusual eye movement.

Amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis is a disorder that disturbs and kills motor neurons (the neurons that control our voluntary muscle movements), making it difficult for patients to move.4 Symptoms of ALS include muscle weakness and cramps, difficulty swallowing, difficulty breathing, and cognitive changes.4  

Hyperkinetic movement disorders

Hyperkinetic movement disorders are often related to excessive involuntary movements. They can be an indication of deeper neurological diseases or injuries to motor neurons or can be induced by drugs, toxins, pressure, or infection. These disorders are more commonly observed in children with neurological disorders than in adults.5 These disorders include:

  • Dystonia: A movement disorder that affects various muscle groups, leading to involuntary muscle contraction, repetitive movements, or abnormal posture, which may be painful.5  
  • Chorea: A disorder that also involves discrete involuntary movements but is distinguished from others due to its unpredictability, starting and ending from different locations, and timing.5
  • Myoclonus: A sudden and involuntary series of muscle contraction and relaxation which creates non-rhythmic muscle jerks. It can affect one or more muscles simultaneously in a predictable sequence (synchronous) or unpredictably.5

Hypokinetic movement disorders

Hypokinetic movement disorders reduce or completely impair a patient’s movement and can also be referred to as hypokinesia. The cause of hypokinesia is often associated with Parkinson’s disease due to its impact on the neurons that affect motor function, but it is also seen in other neurological conditions. The symptoms of hypokinetic movement disorders can be classified into bradykinesia and akinesia:6 

  • Bradykinesia: slow movement, or continued pauses or hesitations in your movement 
  • Akinesia: the inability to perform certain movements. It can be grouped under bradykinesia. 

Causes and mechanisms of movement disorders

Although the exact mechanisms underpinning movement disorders are still unknown, most cases can be linked to genetic factors, neurochemical imbalances, brain injury, or other factors. 

Scientists have studied the genes thought to be involved in movement disorders and found that mutations in certain “risk genes” are major risk factors for, or directly cause these disorders. These mutations may produce faulty proteins that interfere with neurological pathways and cause damage to neurons and other cells. Known risk genes include the IT1 gene in Huntington disease, the C9ORF72 gene in ALS, and the SNCA gene in PD.7,8

Clinical and preclinical studies have recorded the low levels of neurochemicals like dopamine, serotonin, and glutamate in the brains of patients with Parkinson’s disease and Huntington’s disease. This is not just symptomatic - the lack of these neurotransmitters and the neurons producing and using them contributes to the progression of movement disorders and further neuron loss.9  

Brain injuries can cause damage in or impairment to various regions of the brain, such as the thalamus and basal ganglia, leading to dysfunctional movement and movement disorders.10 Other factors thought to be involved in brain injury and movement disorder development include toxin buildup, side effects of medication, progression of other diseases.  

Symptoms of movement disorders

Typical symptoms of movement disorders include:11 

  • Tremors: shaking in one or more parts of the body at rest or performing movements
  • Muscle rigidity: muscle stiffness, which may make it hard for muscles to contract and relax and may cause pain or cramping
  • Unstable posture: difficulty in remaining posture and balance under dynamic or static positions
  • Altered gait: difficulty walking or changes in walking posture due 

Diagnosis and evaluation

The diagnosis of movement disorders requires taking a full medical history and physical examination, as well as neuroimaging and laboratory tests. A healthcare professional will initially evaluate your basic condition -  for example, seeing whether you are experiencing excessive or reduced movement, whether this occurs when you are asleep or awake, the body parts affected by your condition, and whether your movements are regular or random.10

Further tests may be used to assess the impact of your condition on your brain and neurons, your overall motor function, and your quality of life. Neuroimaging technologies like MRI and CT can provide a patient's brain condition, helping with diagnosis and evaluation of the loss of brain tissue and neurons in some situations.12 Intellectual or cognitive function tests may be recommended for young children.5 

Treatment and management

There is currently no cure for movement disorders, but there are pharmacological approaches and surgical interventions which can help control your symptoms and disease.

Medications focusing on the mechanisms of different movement disorders have been developed. For example, Levodopa and dopamine agonists are designed for Parkinson’s disease. These are often combined with physical therapy. Therapists provide exercises and activities that help to recover muscle strength and stimulate relevant pathways in the brain to increase accuracy of movements.13

Deep brain stimulation is currently one of the most beneficial surgical procedures for movement disorders. Its wide range of applications and generally low risk has made it a popular treatment for movement disorders, especially in cases where they seriously affect patients’ quality of life. Deep brain stimulation involves inserting a thin electrode into the affected regions of the brain and placing a battery in the chest. From here, the electrical stimulation of neurons can be controlled from a computer and optimised over time.14

Apart from medication and surgeries, lifestyle modification is also necessary for many patients. Following suitable diets and getting regular exercise may prevent symptom progression while increasing patients’ quality of life.15

Impact on quality of life

Movement disorders pose significant physical and mental challenges on patients and their families. Indeed, patients often suffer from depression and anxiety due to their reduced quality of life.

To draw attention to movement disorders, associations like the International Parkinson and Movement Disorder Society® have accumulated healthcare professionals and researchers who are dedicated to promote greater outcomes in this field and support patients. 

Summary

Movement disorders are a group of neurological conditions that impact your ability to control your movements, potentially leading to an increase or decrease in voluntary or involuntary actions. Diseases of this kind often have uncertain origins, but their onset can be shaped by a combination of genetic and environmental factors. Some of the most common movement disorders are Parkinson's disease, Huntington’s disease, and Amyotrophic lateral sclerosis. There is currently no cure for movement disorders, but researchers and professionals are fighting for better medication and diagnostic methods, allowing these illnesses to be diagnosed and controlled at an early stage.

 References

  1. Fishman L, Health Matters. Movement Disorders Explained [Internet]. 2022 [cited 2024 Feb 19]. Available from: https://healthmatters.nyp.org/movement-disorders-explained/.
  2. Furgiuele A, Pereira FC, Martini S, Marino F, Cosentino M. Dopaminergic regulation of inflammation and immunity in Parkinson’s disease: Friend or foe? Clin Transl. Immunology. 2023;12:e1469. 
  3. Krobitsch S, Kazantsev AG. Huntington’s disease: From molecular basis to therapeutic advances. Int. J. Biochem. Cell Biol. 2011;43:20–4. 
  4. Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. 
  5. Sanger TD, Chen D, Fehlings DL, Hallett M, Lang AE, Mink JW, et al. Definition and classification of hyperkinetic movements in childhood. Mon. Disord. 2010;25:1538–49. 
  6. Avers D, Wong RA. Guccione’s Geriatric Physical Therapy. 4th ed. St Louis: Elsevier; 2019.
  7. Ghasemi M, Brown RH. Genetics of Amyotrophic Lateral Sclerosis. Cold Spring Harb. Perspect. Med. 2017;8:a024125. 
  8. Ezquerra M, Compta Y, Marti MJ. Identifying the genetic components underlying the pathophysiology of movement disorders. Appl. Clin. Genet. 2011;4:81-92. 
  9. Jamwal S, Kumar P. Insight into the emerging role of striatal neurotransmitters in the pathophysiology of Parkinson’s disease and Huntington’s disease: A Review. Curr. Neuropharmacol. 2019;17:165–75. 
  10. Moon D. Disorders of movement due to acquired and Traumatic Brain Injury. Curr. Phys. Med. Rehabil. Rep. 2022;10:311–23. 
  11. Ataullah AHM, De Jesus O. Gait Disturbances. [Updated 2023 Aug 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560610/
  12. Roelofs JJ, Teodoro T, Edwards MJ. Neuroimaging in functional movement disorders. Curr. Neurol. Neurosci. Rep. 2019;19:12. 
  13. Neurological Physiotherapy. Physiotherapy for movement disorders [Internet] [Cited 2023 Oct 12]. Available from: https://neurologicalphysiotherapy.com/neuro-symptoms-we-treat/movement-disorders/ 
  14. University of Pittsburgh School of Medicine, Neurological Surgery. Deep brain stimulation for movement disorders [Internet]. [Cited 2023 Oct 12]. Available from: https://www.neurosurgery.pitt.edu/centers/epilepsy/dbs-movement-disorders 
  15. Lister T. Nutrition and lifestyle interventions for managing Parkinson’s disease: A narrative review. J. Mov. Disord. 2020;13:97–104. 
This content is purely informational and isn’t medical guidance. It shouldn’t replace professional medical counsel. Always consult your physician regarding treatment risks and benefits. See our editorial standards for more details.

Get our health newsletter

Get daily health and wellness advice from our medical team.
Your privacy is important to us. Any information you provide to this website may be placed by us on our servers. If you do not agree do not provide the information.

Shiyi Liang

Medical Biosciences, Imperial College London

Shiyi has several years of experience as a writer for health articles and science reviews. Shiyi has engaged actively in diverse research projects, spanning topics from neuroscience to endocrinology, demonstrating her meticulous approach and passion for research. She is eagerly anticipating more opportunities to delve into the realms of research and science. Furthermore, Shiyi is dedicated to creating informative scientific videos.

my.klarity.health presents all health information in line with our terms and conditions. It is essential to understand that the medical information available on our platform is not intended to substitute the relationship between a patient and their physician or doctor, as well as any medical guidance they offer. Always consult with a healthcare professional before making any decisions based on the information found on our website.
Klarity is a citizen-centric health data management platform that enables citizens to securely access, control and share their own health data. Klarity Health Library aims to provide clear and evidence-based health and wellness related informative articles. 
Email:
Klarity / Managed Self Ltd
Alum House
5 Alum Chine Road
Westbourne Bournemouth BH4 8DT
VAT Number: 362 5758 74
Company Number: 10696687

Phone Number:

 +44 20 3239 9818